Increased secretory leukoprotease inhibitor in patients with nonsmall cell lung carcinoma

Cancer

Volumn 89, Issue 7, 2000, Pages 1448-1456

  Ameshima, Shingo ^a   Ishizaki, Takeshi ^a   Demura, Yoshiki ^a   Imamura, Yoshiaki ^a   Miyamori, Isamu ^a   Mitsuhashi, Hiroaki ^b  

^a UNIVERSITY OF FUKUI   (Japan)

^b TEIJIN LTD   (Japan)

Author keywords

Immunohistochemistry; Nonsmall cell lung carcinoma (NSCLC); Secretory leukoprotease inhibitor (SLPI); Small cell lung carcinoma (SCLC); Tumor marker

Indexed keywords

C REACTIVE PROTEIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; ENZYME IMMUNOASSAY; ENZYME INHIBITION; FEMALE; GLYCOSYLATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL TYPE 2; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

AGED; ANIMAL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGE; PNEUMONIA; PROTEINS; RABBITS; SENSITIVITY AND SPECIFICITY; SERINE PROTEINASE INHIBITORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034306870     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20001001)89:7<1448::AID-CNCR6>3.0.CO;2-Q     Document Type: Article

References (24)

1. The World Health Organization histological typing of lung tumors
2. Pathology of lung cancer: An update
3. Biology of lung cancer
4. Local increase in polymorphonuclear leukocyte elastase is associated with tumor invasiveness in non-small cell lung cancer
5. Local increase of antiprotease and neutrophil elastase-α1 protease inhibitor complexes in lung cancer
6. Localisation of low molecular weight bronchial protease inhibitor in the peripheral human lung
7. Ultrastructural localization of bronchial inhibitor in human airways using protein A - Gold technique
8. Tissue distribution of anti-leukoprotease and lysozyme in humans
9. Secretion of mucus proteinase inhibitor and elafin by Clara cell and type II pneumocyte cell lines
10. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase
11. The 2.5 ÅX-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analyzed in its complex with bovine α-chymotrypsin
12. Antiproteases
13. Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by anti-leukoprotease
14. Proteases
15. Specific cleavage of secretory leukoprotease inhibitor by neutrophil elastase and saliva
16. Differential inhibition of mast cell chymases by secretory leukocyte protease inhibitor
17. α1-Protease inhibitor and mucus proteinase inhibitor in human lung emphysema
18. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis
19. Proteinase inhibitory activities of antileukoprotease are represented by its second COOH-terminal domain
20. Inhibition by recombinant SLPI and half-SLPI (Asn 55 - Ala 107) of elastase and cathepsin G activities: Consequence for neutrophil-platelet cooperation
21. Pharmacological activity of the C-terminal and N-terminal domains of secretory leukoprotease inhibitor in vitro
22. Serum secretory leukoprotease inhibitor levels to diagnose pneumonia in the elderly
23. Keynote address on biostatics and data retrieval